Hypertrophic cardiomyopathy and nephrogenic diabetes insipidus associated with chronic lithium carbonate use

Psychiatry Res. 2020 Sep:291:113153. doi: 10.1016/j.psychres.2020.113153. Epub 2020 May 30.

Abstract

Lithium carbonate is an effective mood stabilizer. We treated a patient for hypertrophic cardiomyopathy due to chronic unsupervised lithium carbonate use. We noted: a) a previously normal ECG; b) the absence of any familiarity for sudden cardiac death; c) the associated nephrogenic diabetes insipidus; d) probable exaggerated lithium plasma concentrations, which had not been monitored over the past few years; and e) the unusual traits of the right ventricle. We would like to stress the need for regular cardiologic follow-up in psychiatric patients treated with lithium carbonate, to minimize its potential cardiac untoward consequences.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antidepressive Agents / adverse effects*
  • Cardiomyopathy, Hypertrophic / chemically induced*
  • Cardiomyopathy, Hypertrophic / diagnostic imaging*
  • Diabetes Insipidus, Nephrogenic / chemically induced*
  • Diabetes Insipidus, Nephrogenic / diagnostic imaging*
  • Drug Administration Schedule
  • Female
  • Humans
  • Lithium Carbonate / adverse effects*

Substances

  • Antidepressive Agents
  • Lithium Carbonate